Tirzepatide – Vial Only (3 Month Plan)
Original price was: ₱22,950.00.₱6,888.00Current price is: ₱6,888.00.
Shed Weight, Gain Confidence – with Tirzepatide 15mg
Experience powerful, doctor-trusted weight loss support in every vial. With 15mg total Tirzepatide (15mg per 3ml), you get 10x more than leading brands at a better price. Fast results. Less cravings. Real confidence.
- FDA-Approval is not required for Compounded Solutions
- with Free Prescription included
Description
Advanced Weight Loss Support — Better Value per Vial
Advanced Weight Loss Support — Better Value per VialWhy spend more on branded tirzepatide (Mounjaro®) pens when you can get 15 mg total tirzepatide in one convenient 3 ml vial for just ₱6,888?
With our premium compounded 3 ml vial, you get:
-
The same active ingredient used in tirzepatide-based weight loss treatments
-
Strong value compared to branded pens
- Flexible dosing using a U-100 insulin syringe
Advanced appetite support. More control. Smarter value.
Tirzepatide Weight Loss Plan: Your Vial vs. Branded Pens
Tirzepatide Weight Loss Plan: Your Vial vs. Branded Pens| Category | Our Vial | Mounjaro® Pens |
|---|---|---|
| Total Tirzepatide | 15 mg (in 3 ml) | Varies per pen strength and prescription |
| Price | ₱6,888 | ₱69,872 (₱8,734 from WATSONS × 8 pens) |
| Price per mg | ₱459 | ₱8,734 |
| Form | Multi-dose vial + insulin syringe | Prefilled auto-injector pens |
| B12 Added | No | No |
| Dose Planning | Adjustable depending on prescribed dosing schedule | Based on fixed pen strength |
| Flexibility | Highly adjustable dosing | Fixed dose delivery |
| Value | You literally save: ₱62,984 | ₱54,992 more expensive |
What is Tirzepatide for Weight Loss?
Originally developed to help manage blood sugar in people with type 2 diabetes, tirzepatide is also FDA-approved for chronic weight management under the brand name Zepbound®. Mounjaro® contains the same active ingredient, tirzepatide, but is FDA-approved for type 2 diabetes management.
Tirzepatide works differently from standard GLP-1 medications because it targets both GIP and GLP-1 receptors, two hormone pathways involved in appetite, blood sugar control, digestion, and fullness. By helping reduce hunger, slow stomach emptying, and support better appetite control, it may help patients reduce calorie intake and achieve steady weight loss over time when combined with proper diet and lifestyle changes.
This medical breakthrough has changed how many people approach weight management, making it easier to stay consistent with healthier habits and see meaningful progress over time.
How Does It Work?
Tirzepatide works by activating two naturally occurring hormone pathways in your body: GIP and GLP-1. These hormones help regulate appetite, blood sugar, digestion, and how full you feel after eating. Because tirzepatide targets both receptors, it offers a more advanced approach compared to standard GLP-1-only medications.
- When tirzepatide is injected, it supports several weight-loss-related effects:
- Reduces Appetite, It signals the brain that you are full, even with smaller portions, helping you eat less without feeling deprived.
- Slows Gastric Emptying, Food stays in your stomach longer, which helps prolong fullness and reduce unnecessary snacking.
- Lowers Cravings, By supporting better blood sugar control and appetite regulation, it may help reduce impulsive eating and sugar cravings.
- Supports Insulin Response, Originally developed for type 2 diabetes, tirzepatide helps improve how the body responds to insulin and regulates blood glucose.
- Dual-Hormone Action, Unlike GLP-1-only medications, tirzepatide activates both GIP and GLP-1 pathways, which may provide stronger appetite and weight management support for some patients.
The result: You may naturally consume fewer calories, feel fuller for longer, and lose weight steadily when tirzepatide is combined with proper diet, lifestyle changes, and medical guidance.
Is It Effective for Weight Loss?
Yes, tirzepatide is clinically proven to be effective for weight loss, even in people without diabetes. In the U.S. FDA’s approval of Zepbound®, the weight-loss brand of tirzepatide, clinical trials showed that patients using the highest approved dose lost an average of 18% of their body weight compared with placebo.
In the SURMOUNT-1 clinical trial, adults with obesity or excess weight who used tirzepatide lost significant weight over 72 weeks, with average reductions reaching around 20% at higher doses. For many patients, that can mean major visible progress when combined with proper diet, lifestyle changes, and medical guidance.
Unlike many weight loss approaches that rely heavily on willpower alone, tirzepatide works at the hormonal level by targeting both GIP and GLP-1 pathways. This helps support appetite control, fullness, blood sugar regulation, and reduced calorie intake over time.
Because of this dual-action mechanism, tirzepatide is considered one of the most advanced medical options for weight management today.
Is It Safe?
Tirzepatide is approved by the U.S. FDA as a safe and effective treatment for both chronic weight management and type 2 diabetes . Semaglutide has been thoroughly studied in large-scale clinical trials with thousands of participants.
Most users tolerate it well, especially with gradual dose escalation.
It is not addictive, not a stimulant, and not hormone-based.
How Is It Taken?
Tirzepatide is administered as a once-weekly subcutaneous injection, meaning it is injected just under the skin, usually in the stomach, thigh, or upper arm. It is typically taken at home using either:
- A prefilled auto-injector pen, such as branded tirzepatide pens, or
- A compounded multi-dose vial drawn with a U-100 insulin syringe for more flexible dosing
Dosing typically starts low and gradually increases to help minimize side effects. A common medical titration schedule starts at 2.5 mg once weekly, then may increase to 5 mg once weekly after 4 weeks, depending on tolerance, treatment goals, and medical guidance. Higher doses may be prescribed gradually if needed.
A compounded vial contains tirzepatide in a different format, with the benefit of adjustable dosing. This can be useful for tailoring your plan, starting conservatively, or adjusting based on your body’s response under proper medical supervision.
Why Mischelyn's Compounded Semaglutide?
Compounded tirzepatide provides the same active ingredient used in tirzepatide-based treatments, in a more flexible vial format. The difference is in the format and delivery method, not the active ingredient itself.
Here’s why many prefer it:
- More cost-efficient compared to branded tirzepatide pens
- Flexible dosing: allows more adjustable weekly dosing based on your plan
- Dual-action support: targets both GIP and GLP-1 pathways for appetite, fullness, and blood sugar regulation
- Convenient multi-dose vial format when used with a U-100 insulin syringe
For those looking for a medically supported, more affordable, and customizable weight loss option, compounded tirzepatide can be a smart alternative under proper medical guidance.
Not Ready to Commit?
You can fill out our Weight Loss Form to learn more!
